Novo Nordisk Obesity Drug Wins FDA Panel Support
An FDA advisory panel recently recommended the approval of Novo Nordisk's injectable drug liraglutide for the treatment of obesity.
Read the rest of the story... »
Source: Highlight HEALTH - Category: Medical Scientists Authors: Walter Jessen Source Type: blogs